Josh Holder

Josh Holder

@Josh_H

Followers1.8K
Following836

Visual journalist. Graphics Editor @nytimes, previously @guardian

Joined on July 30, 2008
@Josh_H Statistics

We looked inside some of the tweets by @Josh_H and found useful information for you.

Inside 100 Tweets

Time between tweets:
4 days
Average replies
37
Average retweets
171
Average likes
254
Tweets with photos
44 / 100
Tweets with videos
6 / 100
Tweets with links
0 / 100
Fun Fact

As of the end of 2012, Twitter has more than 200 million active users.

Experts say the 11-day pause of Johnson & Johnson is partly responsible, but more than a dozen states also saw flattening or falling Pfizer and Moderna first-dose vaccinations in early April. https://t.co/sekYflVwlb

Experts say the 11-day pause of Johnson & Johnson is partly responsible, but more than a dozen states also saw flattening or falling Pfizer and Moderna first-dose vaccinations in early April. https://t.co/sekYflVwlb

The US has entered a new phase in its vaccination campaign in which supply often outstrips demand. The average number of people getting a first or single dose each day has fallen by about 50 percent from the peak on April 13. Full story with @amyswalk: https://t.co/noH2UTSbS8

13
38
64
New graphic on our US vaccination tracker: How each state compares to the national share of vaccinated people.

Southern states such as Mississippi and Alabama are falling behind while the Northeast pulls ahead.

https://t.co/IUSxp7Jzpj https://t.co/MWvfOozbue

New graphic on our US vaccination tracker: How each state compares to the national share of vaccinated people. Southern states such as Mississippi and Alabama are falling behind while the Northeast pulls ahead. https://t.co/IUSxp7Jzpj https://t.co/MWvfOozbue

Our story on the rise of B.1.1.7 in Europe is on the front page of today’s print @nytimes https://t.co/pDAVP0s6ML https://t.co/SeXw1gvaHw
2

Our story on the rise of B.1.1.7 in Europe is on the front page of today’s print @nytimes https://t.co/pDAVP0s6ML https://t.co/SeXw1gvaHw

Europe has once again swelled with new coronavirus cases, driving a worrisome global surge. But this time, the rise in new cases is being propelled by a variant first seen in Britain, which swept that nation in December. https://t.co/GyHzkaCAzO

344
1K
1K

We looked at the rise of variants across Europe — B.1.1.7 in particular — and how dangerous this virus can be @Josh_H @benjmueller https://t.co/3icJjvEAkL

63
207
299
More than 90% of all samples analyzed in the UK, Ireland and Poland at the end of March were classified as B.1.1.7, but it has spread rapidly across the continent since early January. https://t.co/r2fJfCgGgw

More than 90% of all samples analyzed in the UK, Ireland and Poland at the end of March were classified as B.1.1.7, but it has spread rapidly across the continent since early January. https://t.co/r2fJfCgGgw

18
73
112

The world’s richest countries have received 86% of vaccines administered so far. Only 0.1% of doses have been administered in low-income countries. The disparity, experts say, lies in how and when deals for doses were struck with drug companies. https://t.co/vcdwDD18Or

155
1K
2K
With much of the supply of the Pfizer and Moderna vaccines already spoken for by wealthier countries, China, India and Russia have become important suppliers of vaccines to lower-income countries. https://t.co/1jqLurCRGP

With much of the supply of the Pfizer and Moderna vaccines already spoken for by wealthier countries, China, India and Russia have become important suppliers of vaccines to lower-income countries. https://t.co/1jqLurCRGP

The result is that just 0.1% of vaccine doses have been administered in low income countries so far. https://t.co/VGHeJ6TTju

The result is that just 0.1% of vaccine doses have been administered in low income countries so far. https://t.co/VGHeJ6TTju

Low-income countries made their first significant vaccine purchase agreements in January 2021 — eight months after the United States and the United Kingdom made their first deals. https://t.co/XEdWQy5mVT

Low-income countries made their first significant vaccine purchase agreements in January 2021 — eight months after the United States and the United Kingdom made their first deals. https://t.co/XEdWQy5mVT

The world’s richest countries are storming ahead in the vaccination race. 86% of vaccine doses have been administered in high and upper-middle income countries. The reason lies in how — and when — deals for doses were struck. Story with @collinskeith: https://t.co/UYhEOIePgo

17
51
133

Nearly a third of adults in New York City and almost half of those 65 and older have received at least one dose of a Covid-19 vaccine. But there are income and racial disparities in the city’s rollout. See our analysis of the vaccine campaign so far. https://t.co/Q4H2cQ4yGv

8
42
143

Communities of color in the U.S. have received a smaller share of available vaccines, according to our analysis. The vaccination rate for Black Americans is half that of white people, and the gap for Hispanic people is even larger. https://t.co/fTuDUvlf6h

22
170
242
Josh Holder
2 months ago
Every state has a gap between the Black share of the overall population and the vaccinated population. https://t.co/TRP3idQpXL

Every state has a gap between the Black share of the overall population and the vaccinated population. https://t.co/TRP3idQpXL

Josh Holder
2 months ago

Communities of color are being vaccinated at lower rates than their white counterparts, despite bearing the brunt of the pandemic in the US. Read our full story: https://t.co/drFAJfcbz5 With @amyswalk @singhvianjali @gebeloffnyt @yag1310

2
8
12
Josh Holder
2 months ago
After peaking at more than 750,000 new cases each day, the pandemic is receding. New cases have halved, driven largely by improvements in the same countries that had devastating outbreaks this winter. But will it last? w/ @atmccann + @LaurenLeatherby 

https://t.co/9dc5i6wnxr https://t.co/TMNAk9UCn0 https://t.co/UZZnpC5Y59

After peaking at more than 750,000 new cases each day, the pandemic is receding. New cases have halved, driven largely by improvements in the same countries that had devastating outbreaks this winter. But will it last? w/ @atmccann + @LaurenLeatherby https://t.co/9dc5i6wnxr https://t.co/TMNAk9UCn0 https://t.co/UZZnpC5Y59

A month ago, the pandemic looked bleak -- more than 750,000 cases were tallied worldwide in a single day -- but the last month has brought a surprisingly fast turnaround. Will it last? w/ @Josh_H @LaurenLeatherby https://t.co/mNMTLU1sf5

19
29
90
Next Page